Serotonergic/glutamatergic interactions: Potentiation of phencyclidine-induced stimulus control by citalopram

Pharmacology Biochemistry and Behavior

Volumn 81, Issue 3, 2005, Pages 694-700

  Winter, J C ^a   Eckler, J R ^a   Rice, K C ^b   Rabin, R A ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Citalopram; Drug discrimination; Phencyclidine; Rat; SB 242084; SDZ SER 082

Indexed keywords

2,5 DIMETHOXY 4 METHYLAMPHETAMINE; 4,5,7A,8,9,10,11,11A OCTAHYDRO 10 METHYL 7H INDOLO[1,7 BC][2,6] NAPHTHYRIDINE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; CITALOPRAM; LYSERGIDE; PHENCYCLIDINE; SEROTONIN 2C ANTAGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROL; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; EXPERIMENT; HYPOTHESIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; SEROTONINERGIC SYSTEM; STIMULUS; TASK PERFORMANCE; TIME;

AMINOPYRIDINES; ANALYSIS OF VARIANCE; ANIMALS; CITALOPRAM; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; INDOLES; MALE; PHENCYCLIDINE; PIPERAZINES; RATS; RATS, INBRED F344; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 22044448903     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.03.022     Document Type: Article

References (65)

1. G.K. Aghajanian, and G.J. Marek Serotonin and hallucinogens Neuropsychopharmacology 21 1999 16S 23S
2. G.K. Aghajanian, and G.J. Marek Serotonin model of schizophrenia: emerging role of glutamate mechanisms Brain Res Rev 31 2000 302 312
3. N.A. Anis, S.C. Berry, N.R. Burton, and D. Lodge The dissociative anesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurons by N-methyl-aspartate Br J Pharmacol 79 1983 565 575
4. 2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex Eur J Neurosci 11 1999 3064 3072
5. K.R. Bonson, and D.L. Murphy Alterations in responses to LSD in humans associated with chronic administration of tricyclic antidepressants, monoamine oxidase inhibitors or lithium Behav Brain Res 73 1996 229 233
6. K. Brosen, and C.A. Naranjo Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram Eur Neuropsychopharmacol 11 2001 275 283
7. R.G. Browne, and B.T. Ho Role of serotonin in the discriminative stimulus properties of mescaline Pharmacol Biochem Behav 3 1975 429 435
8. F.P. Bymaster, W. Zhang, P.A. Carter, J. Shaw, E. Chernet, and L. Phebus Fluoxetine but not other selective serotonin uptake inhibitors increases norepinephrine and dopamine extracellular levels in prefrontal cortex Psychopharmacology 160 2002 353 361
9. 2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine Eur J Pharmacol 257 1994 27 38
10. A. Carlsson, N. Waters, S. Holm-Waters, J. Tedroff, M. Nilsson, and M.L. Carlsson Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence Annu Rev Pharmacol Toxicol 41 2001 237 260
11. 1A receptors might control the output of cortical glutamatergic neurons in rat cingulate cortex Brain Res 989 2003 42 51
12. 2 receptor ligand adatanserin Neurochem Int 40 2002 203 209
13. A. Dekeyne, I. Loretta, and M.J. Millan Following long-term training with citalopram, both mirtazapine and mianserin block its discriminative stimulus properties Psychopharmacology 153 2001 389 393
14. J.R. Eckler, M. Doat, R.A. Rabin, and J.C. Winter Potentiation of DOM-induced stimulus control by fluoxetine and citalopram: the role of pharmacokinetics Life Sci 71 2002 1341 1347
15. 2C receptor-mediated interaction between 2,5-dimethoxy-4- methylamphetamine [DOM] and citalopram in the rat Pharmacol Biochem Behav 79 2004 25 30
16. 2C receptors in the stimulus effects of hallucinogenic drugs: I. Antagonist correlation analysis Psychopharmacology 121 1995 347 356
17. 2C receptors in the stimulus effects m-chlorophenylpiperazine Psychopharmacology 119 1995 222 230
18. 2C receptors in the stimulus effects of hallucinogenic drugs: III. The mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion Psychopharmacology 121 1995 364 372
19. D. Fiorella, S. Helsley, J.C. Winter, and R.A. Rabin Potentiation of LSD-induced stimulus control by fluoxetine in the rat Life Sci 59 1996 PL283 PL287
20. E.W. Fish, S. Faccidoma, S. Gupta, and K.A. Miczek Anxiolytic-like effects of escitalopram, citalopram and R-citalopram in maternally separated mouse pups J Pharmacol Exp Ther 308 2004 474 480
21. 2 antagonists Eur J Pharmacol 91 1983 189 196
22. 2 involvement in the mechanism of action of hallucinogenic agents Life Sci 35 1984 2505 2511
23. I.D. Hirschhorn, and J.C. Winter Mescaline and lysergic acid diethylamide [LSD] as discriminative stimuli Psychopharmacology 22 1971 64 71
24. D. Hoyer, D.E. Clark, J.R. Fozard, P.R. Hartig, G.R. Martin, and E.J. Mylecharane International Union of Pharmacology classification of receptors for 5-hydroxytryptamine [serotonin] Pharmacol Rev 46 1994 157 203
25. D. Hoyer, J.P. Hannon, and G.R. Martin Molecular, pharmacological, and functional diversity of 5-HT receptors Pharmacol Biochem Behav 71 2002 533 554
26. J. Hyttel Pharmacological characterization of selective serotonin reuptake inhibitors [SSRIs] Int Clin Psychopharmacol 9 Suppl. 1 1994 19 26
27. J. Hyttel, K.P. Bogeso, J. Perregaard, and C. Sanchez The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer J Neural Transm Gen Sect 88 1992 157 160
28. K.P. Keenan, P.F. Smith, P. Hertzog, K. Soper, G.C. Ballam, and R.L. Clark The effects of overfeeding and dietary restriction on Sprague-Dawley rat survival and early pathology biomarkers of aging Toxicol Pathol 22 1994 300 315
29. 2C receptor antagonist Neuropharmacology 36 1997 609 620
30. W. Koek N-Methyl-d-aspartate antagonists and drug discrimination Pharmacol Biochem Behav 64 1999 275 281
31. E.M. Laurenzana, and S.M. Owens Metabolism of phencyclidine by human liver microsomes Drug Metab Dispos 25 1997 557 563
32. 1A receptor antagonist, (+)-WAY 100135, on stereotyped behavior induced by the NMDA receptor antagonist dizocilpine in rats Eur J Pharmacol 242 1993 99 104
33. 2A receptors regulate evoked glutamate release from rat cerebellar mossy fibers J Pharmacol Exp Ther 299 2001 1106 1111
34. H. Markel, A. Lec, R.D. Holmes, and E.F. Domino LSD flashback syndrome exacerbated by selective serotonin reuptake inhibitor antidepressants in adolescents J Pediatr 125 1994 817 819
35. P. Martin, M.L. Carlsson, and S. Hjorth Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats Neuroreport 9 1998 2985 2988
36. 2A receptors through a glutamate-dependent mechanism J Neurosci 21 2001 9856 9866
37. 2A receptor activation J Neurosci Res 67 2002 399 405
38. 2C receptors are involved in the discriminative stimulus effects of citalopram in rats Psychopharmacology 142 1999 432 434
39. M.J. Millan, F. Lejeune, and A. Gobert Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic, and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents J Psychopharmacol 14 2000 114 138
40. R.J. Milne, and K.L. Goa Citalopram. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depressive illnesses Drugs 41 1991 450 477
41. B. Moghaddam, and B.W. Adams Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats Science 281 1998 1349 1352
42. A. Mork, M. Kreilgaard, and C. Sanchez The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats Neuropharmacology 48 2003 167 173
43. J.W. Muschamp, M.J. Regina, E.M. Hull, J.C. Winter, and R.A. Rabin LSD and DOM increase extracellular glutamate in rat prefrontal cortex Brain Res 1023 2004 134 140
44. D.E. Nichols Hallucinogens Pharmacol Ther 101 2004 131 181
45. 2A receptor affinity J Med Chem 38 1995 28 33
46. 1B receptors for citalopram-induced hypothermia in the rat Psychopharmacology 154 2001 429 434
47. P.J. Pauwels 5-HT receptors and their ligands Tocris Rev 25 2003 1 10
48. 2 agonist-induced Arc gene expression in the rat cortex Neuropharmacology 46 2004 331 339
49. 2-receptor-mediated cGMP formation: the essential role of glutamate Brain Res 1003 2004 168 175
50. C. Sanchez R-citalopram attenuates anxiolytic effects of escitalopram in a rat ultrasonic vocalization model Eur J Pharmacol 464 2003 155 158
51. J.L. Scruggs, D. Schmidt, and A.Y. Deutch The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane [DOI] increases cortical extracellular glutamate levels in rats Neurosci Lett 346 2003 137 140
52. E. Spina, M.G. Scordo, and C. D'Arrigo Metabolic drug interactions with new psychotropic agents Fundam Clin Pharmacol 17 2003 517 538
53. 1A serotonin receptors in the rat brain Brain Res 756 1997 84 99
54. 1A serotonin receptors, attenuates psychotomimetic effects of MK-801 Neuropsychopharmacology 23 2000 547 559
55. J.C. Winter Blockade of the stimulus properties of mescaline by a serotonergic antagonist Arch Int Pharmacodyn 214 1975 250 253
56. J.C. Winter Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine J Pharmacol Exp Ther 204 1978 416 423
57. J.C. Winter, and R.A. Rabin Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus Pharmacol Biochem Behav 30 1988 617 624
58. J.C. Winter, S.E. Helsley, D. Fiorella, and R.A. Rabin The acute effects of monoamine reuptake inhibitors on the stimulus effects of hallucinogens Pharmacol Biochem Behav 63 1999 607 613
59. J.C. Winter, D.J. Fiorella, S.E. Helsley, and R.A. Rabin Partial generalization of [-]DOM to fluvoxamine in the rat: implications for SSRI-induced mania and psychosis Int J Neuropsychopharmacol 2 1999 165 172
60. J.C. Winter, M. Doat, and R.A. Rabin Potentiation of DOM-induced stimulus control by non-competitive NMDA antagonists: a link between the glutamatergic and serotonergic hypotheses of schizophrenia Life Sci 68 2000 337 344
61. 1A receptors Pharmacol Biochem Behav 65 2000 75 82
62. J.C. Winter, J.R. Eckle, M.M. Doat, and R.A. Rabin The effects of acute and chronic treatment with fluoxetine and citalopram on stimulus control by DOM Pharmacol Biochem Behav 74 2002 95 101
63. J.C. Winter, J.R. Eckler, and R.A. Rabin Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with phencyclidine and LSD as discriminative stimuli Psychopharmacology 172 2004 233 240
64. Q. Yan, M.E.A. Reith, P.C. Jobe, and J.W. Dailey Dizocilpine [MK-801] increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats Brain Res 765 1997 149 158
65. 3H]phencyclidine binding in rat central nervous system Proc Natl Acad Sci U S A 76 1979 5372 5376